Genome sequencing applied to cancer patients demonstrates that 3% of colorectal cancers and 7% of endometrial cancers contain mutations involving the exonuclease domain of POLE and are associated with high levels of single-nucleotide polymorphisms (SNPs) in this gene [10,11,49]. Here, POLE is linked to colorectal cancer.